Litcius/Paper detail

α-Synuclein PET and Parkinson Disease Therapeutic Trials: Ever the Twain Shall Meet?

John Seibyl

2022Journal of Nuclear Medicine13 citationsDOIOpen Access PDF

Abstract

Neurodegenerative disorders are common brain afflictions with increasing prevalence in countries with aging populations. This is true for the two most common neurodegenerative disorders, Alzheimer disease (AD) and Parkinson disease (PD), both demonstrating increases in prevalence over the last

Topics & Concepts

DiseaseParkinson's diseaseMedicineInternal medicineParkinson's Disease Mechanisms and TreatmentsNeurological disorders and treatmentsNuclear Receptors and Signaling
α-Synuclein PET and Parkinson Disease Therapeutic Trials: Ever the Twain Shall Meet? | Litcius